Showing results (1-10 of 816) with videos related to
Sort By:
Pageof 82
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 15, 2013
PARP Inhibitors for BRCA1/2 mutation-associated and BRCA-like malignanciesJ-M Lee, J A Ledermann, E C KohnAnnals of Oncology : Official Journal of the European Society for Medical Oncology|October 15, 2010
Proteomics as a guiding tool for more effective personalized therapyJ-M Lee, E C KohnAnnals of Oncology : Official Journal of the European Society for Medical Oncology|November 23, 2013
Clinical implications of using molecular diagnostics for ovarian cancersE C Kohn, S Romano, J-M LeeAnnals of Oncology : Official Journal of the European Society for Medical Oncology|December 13, 2017
Front-line therapy of advanced ovarian cancer: new approachesJ A LedermannInternational Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 11, 2008
Lessons learned from a decade of clinical trials of high-dose chemotherapy in ovarian cancerJ A LedermannAnnals of Oncology : Official Journal of the European Society for Medical Oncology|May 4, 2016
PARP inhibitors in ovarian cancerJ A LedermannPharmacology & Therapeutics|November 1, 1991
Invasion and metastasis: biology and clinical potentialE C KohnEuropean Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 18, 2000
Novel chemotherapeutic agents in colorectal cancerM P Napier, J A LedermannPageof 82